Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Pharming Group reports interim financial results for the first nine months of 2018
Compared with the first nine months of 2017 (on a like-for-like basis):
Product revenues up 74% to €97.7 million, operating profit up 144% to €31.0 million, net profit up 131% to 11.7 million
Compared with the last quarter ended 30 June 2018:
Product revenues up 30% to €38.6 million, operating profit up 82% to €14.7 million, net profit up 77% to €5.4 million
Cash increased to €72.2 million (after €7.5m repayment of debt) to invest in key growth drivers
..."This data therefore supports additional clinical investigations for the use of rhC1INH in a new indication where there is significant unmet medical need."...
link to the article:
https://www.pharming.com/pharming-reports-positive-data-from-first-investigator-initiated-study-of-rhc1-inhibitor-ruconest-in-contrast-induced-nephropathy/
and still very promising, because ABLX rejected the proposal
http://www.ablynx.com/
anyone who knows something about this future biotech multi-bagger? (current price targets up to 70% above today's price)
listed on Euronext Brussels and relatively new on Nasdaq (successfull IPO last month, they raised 175 million dollar)
first drug candidate was approved + very promising pipeline.
"Ablynx is a Belgian biopharmaceutical company engaged in the development of Nanobodies®, proprietary therapeutic proteins based on single-domain antibody fragments.
Today, the Company has approximately 45 proprietary and partnered programmes in development in various therapeutic areas including inflammation, haematology, immuno-oncology, oncology and respiratory disease."
I really think you're the smartest guy on this board...
Did it really go down from .001 to .0001? Thought it was at .0001 all the time...
What does that mean?
ain't gonna happen
usefull background information
Salman Khokhar
EARLY CAREER: Played a role in growing the international business for both Calvin Klein and Donna Karan. At CK, directed the jeans division in Europe, while working at the company through 2 mergers, eventually playing a key management role within the $1.5 billion distribution network at Warnaco. Upon moving to Donna Karan, the concentration was mainly on repositioning, brand segmentation, and new-entry into Europe and Asia. DKNY grew to $1.2 billion prior to its sale to LVMH in 2001, and during the transition, KOKA CONSULTING was established.
Over the last 10 years, I have advised CEO's and held operational roles for growth and turnaround through international expansion and licensing with brands that include - DKNY, Oscar de la Renta, Ralph Lauren, Via Spiga, Lulu Lemon, Emmanuel Ungaro, Adidas Y3, Sachin + Babi, and Tranoi.
Simultaneously through KOKA we continue to assist private equity firms on pre-deal valuation, deep dive due diligence, and operational management at mid size companies looking to grow through licensing and emerging market expansion.
We also work with designers and start up ventures in the luxury lifestyle space to build business plans and brand strategies to grow sustainable companies. Designers have included Carlos Miele, Alberto Moretti, Giambattista Valli, Ozwald Boateng, Laura Vela, Pink Magnolia, Be Inthavong, along with industry related projects in hospitality, real estate, and online publications.
ACADEMIC SPEAKING 2010-2012
Have lead speaking engagements, case studies, workshops at Harvard Business School, MIT Sloan, MIT Media Lab, NYU Stern, Cornell Johnson School, University of Miami, USC Marshall, Parsons New School, FIT, and INSEAD Fontainebleau FR.
Specialismen:Operational Management
Wholesale Sales & Merchandising
Strategy Development & Execution
Marketing Creative / Online & Social Media
Direct Retail Collaborations
Category Extensions & Licensing
International Expansion for US & EU brands into BRIC markets through Franchising & JV
Additionally M&A advisory to brands and designers seeking capital investments and or strategic partnerships to grow. Work with Private Equity to provide valuations, operational expertise in retail and luxury.
Anyone knows when Q1 is expected?
Will never give my money to delmar again
You keep buying every day? You own cgrw already?
Already 700$. Keep it alive guys
so glad I sold at .99
seems it's gonna happen
Hit those 2's before it's too late!!! $$$ GO BTZO $$$
Impressive volume...again...
Quiet board. Pump is over, nothing more to see here. No more interest, volume slowing day after day. Definitely going back down. Watch my words. Been saying this for 2 weeks. Guess what happened?
Ok, thanks. Open tomorrow?
Question, why markets were closed today?
Not dead. Just a matter of time...
Keep on dreaming guys, it's not gonna happen anymore
At least the Store name above the front door is fake (photoshop)
Look at the picture at the website and compare with street view
seems to be stuck already a few days
Hahaha, already warned you yesterday
or almost cooling down after a 3800% gain...?
try selling before it's melting
I was in at 10$, means before the 1/10000 RS
had a 90% loss, never took the risk to average down.
Good luck to all of you guys.
I'm glad I'm out...
Zeker weten! Go BTZO $$$
GM all. Still waiting for a little action here
Following this one very closely. If it moves, I'll buy another package
100k
Time to make a ride?
A little more activity at this board would be good
Me too, hope people will pick this stock up again.
even up 700% with moderate volume
Holy $hit, just removed my sell order at 3's.
People can buy my 0.001*'s GO KGRI !!!
that's great GO KGRI $$$
I'm loaded and ready